Overview

A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia

Status:
Terminated

Trial end date:
2015-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the effect of oral paliperidone extended-release and oral risperidone immediate-release on cognitive function, especially the category fluency of Cognitive Abilities Screening Instrument, Chinese version (CASI C-2.0), in patients with an established diagnosis of schizophrenia.

Phase:

Phase 4

Details

Lead Sponsor:

Johnson & Johnson Taiwan Ltd

Treatments:

Paliperidone Palmitate
Risperidone